Knights Of Columbus Asset Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Knights Of Columbus Asset Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$98.98 - $115.74 $1.09 Million - $1.28 Million	11,056 Added 64.47%	28,204 $3.26 Million
Q2 2023 Jul 31, 2023	SELL	$96.34 - $112.38 $14,643 - $17,081	-152 Reduced 0.88%	17,148 $1.76 Million
Q1 2023 May 01, 2023	BUY	$107.32 - $113.5 $1.23 Million - $1.31 Million	11,505 Added 198.53%	17,300 $1.89 Million
Q4 2022 Jan 31, 2023	SELL	$62.39 - $113.8 $3,930 - $7,169	-63 Reduced 1.08%	5,795 $659,000
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $14,258 - $20,490	-242 Reduced 3.97%	5,858 $363,000

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $4,128 - $6,050	52 Added 0.86%	6,100 $487,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $164,198 - $208,639	1,900 Added 45.81%	6,048 $636,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $408,826 - $497,386	4,148 New	4,148 $447,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.